REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gara es Tarsai Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: GARA es Tarsai Gyogyszerkereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Gara es Tarsai Bt. is based in Hungary, with the head office in Nagyatad. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on November 10, 1995. 14 (2024) employees currently work for Gara es Tarsai Bt.. In 2023, the company reported a net sales revenue increase of 5.16%. During that time, Gara es Tarsai Bt.’s total assets decreased by 1.2%. In 2023, Gara es Tarsai Bt.’s net profit margin decreased by 1.4%.

Headquarters
Koranyi utca 4.
Nagyatad; Somogy; Postal Code: 7500

Contact Details: Purchase the Gara es Tarsai Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Gara es Tarsai Bt. report to view the information.
Outstanding Shares:
Purchase the Gara es Tarsai Bt. report to view the information.
Registered Capital:
Purchase the Gara es Tarsai Bt. report to view the information.
Financial Auditors:
Purchase the Gara es Tarsai Bt. report to view the information.
Incorporation Date:
November 10, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Gara es Tarsai Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.16%▲
Total operating revenue
5.17%▲
Operating profit (EBIT)
-25.37%▼
EBITDA
-23.39%▼
Net Profit (Loss) for the Period
-36.5%▼
Total assets
-1.2%▼
Total equity
-2.85%▼
Operating Profit Margin (ROS)
-1.21%▼
Net Profit Margin
-1.4%▼
Return on Equity (ROE)
-5.69%▼
Quick Ratio
-0.07%▼
Cash Ratio
-0.04%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo